ML Bio Solutions, Inc.
4 clinical trials · Sponsor
◉ Watch ML Bio Solutions, Inc.
| Record | Firm | Date |
|---|---|---|
| Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9 (NCT07678775) | ML Bio Solutions, Inc. | 2026-06-05 |
| Study of BBP-418 in Patients With LGMD2I (NCT04800874) | ML Bio Solutions, Inc. | 2021-02-18 |
| Biomarker Development in LGMD2i (NCT04202627) | ML Bio Solutions, Inc. | 2019-12-01 |
Track ML Bio Solutions, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.